1. Home
  2. LGND vs MCHB Comparison

LGND vs MCHB Comparison

Compare LGND & MCHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • MCHB
  • Stock Information
  • Founded
  • LGND 1987
  • MCHB 1905
  • Country
  • LGND United States
  • MCHB United States
  • Employees
  • LGND 68
  • MCHB N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • MCHB Major Banks
  • Sector
  • LGND Health Care
  • MCHB Finance
  • Exchange
  • LGND Nasdaq
  • MCHB Nasdaq
  • Market Cap
  • LGND 3.2B
  • MCHB 2.9B
  • IPO Year
  • LGND 1992
  • MCHB N/A
  • Fundamental
  • Price
  • LGND $205.69
  • MCHB $15.41
  • Analyst Decision
  • LGND Strong Buy
  • MCHB Hold
  • Analyst Count
  • LGND 8
  • MCHB 1
  • Target Price
  • LGND $144.71
  • MCHB $14.50
  • AVG Volume (30 Days)
  • LGND 139.7K
  • MCHB 343.7K
  • Earning Date
  • LGND 08-05-2025
  • MCHB 10-30-2025
  • Dividend Yield
  • LGND N/A
  • MCHB N/A
  • EPS Growth
  • LGND N/A
  • MCHB N/A
  • EPS
  • LGND N/A
  • MCHB 0.90
  • Revenue
  • LGND $181,488,000.00
  • MCHB $566,737,000.00
  • Revenue This Year
  • LGND $18.41
  • MCHB N/A
  • Revenue Next Year
  • LGND $18.87
  • MCHB $9.48
  • P/E Ratio
  • LGND N/A
  • MCHB $16.49
  • Revenue Growth
  • LGND 53.40
  • MCHB N/A
  • 52 Week Low
  • LGND $81.74
  • MCHB $6.46
  • 52 Week High
  • LGND $129.90
  • MCHB $15.40
  • Technical
  • Relative Strength Index (RSI)
  • LGND 59.63
  • MCHB N/A
  • Support Level
  • LGND $198.82
  • MCHB N/A
  • Resistance Level
  • LGND $209.10
  • MCHB N/A
  • Average True Range (ATR)
  • LGND 7.14
  • MCHB 0.00
  • MACD
  • LGND -0.67
  • MCHB 0.00
  • Stochastic Oscillator
  • LGND 53.60
  • MCHB 0.00

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About MCHB Mechanics Bancorp Class A Common Stock

Mechanics Bancorp is an independent, full-service community bank. It provides personal banking, business banking, trust and estate, brokerage and wealth management services. Mechanics' retail banking products include personal checking, savings and loan products (including credit card, home equity, home mortgage and secured/unsecured loans), online banking and wealth management services (including trust and estate, investment management and financial planning services). Mechanics' banking products and services for businesses include business checking and savings accounts, business debit cards, online banking, cash management services, wealth management services, business credit cards, commercial real estate loans, equipment leasing and loans guaranteed by the Small Business Administration.

Share on Social Networks: